stivarga
bayer new zealand limited - regorafenib monohydrate 41.49mg equivalent to regorafenib 40 mg - tablet - 40 mg - active: regorafenib monohydrate 41.49mg equivalent to regorafenib 40 mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry pink 85g35294 povidone - stivarga is indicated for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies. these include fluoropyrimidine-based chemotherapy, an anti-vegf therapy, and an anti-egfr therapy.
inactivated poliomyelitis vaccine suspension for injection
bilthoven biologicals b.v antonie van leeuwenhoeklaan 9-13, bilthoven, 3721 - inactivated poliomyelitis virus type 1 - suspension for injection - inactivated poliomyelitis virus type 1 -40 - viral vaccines: poliomyelitis vaccines
inactivated rabie injection
inactivated rabies vaccine - injection - inactivated rabies vaccine - antibacterials for systemic use
cevac new k (inactivated, oil adjuvated vaccine) injection
ceva-phylaxia veterinary biologicals co ltd 1107 budapest, szállás utca 5 - inactivated newcastle disease virus strain ndv-sz - injection - inactivated newcastle disease virus strain - immunologicals for domestic fowl: inactivated
cevac® broiler nd k (inactivated, oil emulsion injection
ceva-phylaxia veterinary biologicals co ltd 1107 budapest, szállás utca 5 - inactivated newcastle disease virus strain ndv-sz - injection - inactivated newcastle disease virus strain ndv-sz - immunologicals for domestic fowl: inactivated
semprex d- acrivastine and pseudoephedrine hydrochloride capsule
endo pharmaceuticals inc. - acrivastine (unii: a20f9xai7w) (acrivastine - unii:a20f9xai7w), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - acrivastine 8 mg - semprex-d capsules are indicated for relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion. semprex-d capsules should be administered when both the antihistaminic activity of acrivastine and the nasal decongestant activity of pseudoephedrine are desired (see clinical pharmacology ). the efficacy of semprex-d capsules beyond 14 days of continuous treatment in patients with seasonal allergic rhinitis has not been adequately investigated in clinical trials. semprex-d capsules have not been adequately studied for effectiveness in relieving the symptoms of the common cold. semprex-d capsules are contraindicated in patients with a known sensitivity to acrivastine, other alkylamine antihistamines (e.g., triprolidine), pseudoephedrine, other sympathomimetic amines (e.g., phenylpropanolamine), or to any other components of the formulation. semprex-d capsules are contraindicated in patients with severe hypertension or severe coronary arte
inactivated poliomyelitis vaccine (diploid cell origin) - ipv solution
sanofi pasteur limited - inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney - solution - 8unit; 32unit; 40unit - inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1 8unit; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett 32unit; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney 40unit - vaccines
activated charcoal suspension
hf acquisition co llc, dba healthfirst - activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10) - actidose® with sorbitol and actidose®-aqua should be used in a supervised medical facility or under the direction of a physician or poison control center. actidose® with sorbitol and actidose®-aqua are indicated in the management of many types of poisoning emergencies when a toxin has been ingested or when indicated for a limited number of systemic poisonings resulting from parenteral overdosage or when the toxin has been totally absorbed. if physiologic conditions are optimal, activated charcoal most effectively adsorbs toxins with a molecular weight of 100 - 1,000 daltons (amu’s).1 activated charcoal may not be as effective in adsorbing low molecular weight substances such as aliphatic alcohols (methanol, isopropanol, ethanol, etc.) metals (iron, lead, mercury, etc.) and elements such as lithium.2. two animal studies have demonstrated that very toxic and low molecular weight cyanide compounds are adsorbed by activated charcoal.21,22 the use of activated charcoal in toxic emergencies involving these substanc
nobilis gumboro + nd combined inactivated vaccine against gumboro and newcastle disease
intervet australia pty limited - inactivated gumboro virus; inactivated newcastle disease virus antigen - misc. vaccines or anti sera - inactivated gumboro virus biological-virus active 0.0 vnu/dose; inactivated newcastle disease virus antigen vaccine-viral active 0.0 hi/dose - immunotherapy - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - infectious bursal disease | newcastle disease | bursal disease
nobilis gumboro inactivated vaccine
intervet australia pty limited - inactivated infectious bursal disease virus (strain d78) - misc. vaccines or anti sera - inactivated infectious bursal disease virus (strain d78) vaccine-viral active 0.0 p - immunotherapy - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - infectious bursal disease | bursal disease